Nemunaitis J - Search Results

1

Personalized cancer approach: using RNA interference technology.

Nemunaitis J, Rao DD, Liu SH, Brunicardi FC. Nemunaitis J, et al. World J Surg. 2011 Aug;35(8):1700-14. doi: 10.1007/s00268-011-1100-0. World J Surg. 2011. PMID: 21557010 Review.

2

Small interfering RNA for experimental cancer therapy.

Tong AW, Zhang YA, Nemunaitis J. Tong AW, et al. Among authors: nemunaitis j. Curr Opin Mol Ther. 2005 Apr;7(2):114-24. Curr Opin Mol Ther. 2005. PMID: 15844618 Review.

3

Individualised cancer therapeutics: dream or reality? Therapeutics construction.

Shen Y, Senzer N, Nemunaitis J. Shen Y, et al. Among authors: nemunaitis j. Expert Opin Biol Ther. 2005 Nov;5(11):1427-41. doi: 10.1517/14712598.5.11.1427. Expert Opin Biol Ther. 2005. PMID: 16255647 Review.

4

Nonviral delivery vehicles for use in short hairpin RNA-based cancer therapies.

Vorhies JS, Nemunaitis J. Vorhies JS, et al. Among authors: nemunaitis j. Expert Rev Anticancer Ther. 2007 Mar;7(3):373-82. doi: 10.1586/14737140.7.3.373. Expert Rev Anticancer Ther. 2007. PMID: 17338656 Review.

5

Proof concept for clinical justification of network mapping for personalized cancer therapeutics.

Nemunaitis J, Senzer N, Khalil I, Shen Y, Kumar P, Tong A, Kuhn J, Lamont J, Nemunaitis M, Rao D, Zhang YA, Zhou Y, Vorhies J, Maples P, Hill C, Shanahan D. Nemunaitis J, et al. Among authors: nemunaitis m. Cancer Gene Ther. 2007 Aug;14(8):686-95. doi: 10.1038/sj.cgt.7701057. Epub 2007 Jun 1. Cancer Gene Ther. 2007. PMID: 17541424

6

MicroRNA profile analysis of human prostate cancers.

Tong AW, Fulgham P, Jay C, Chen P, Khalil I, Liu S, Senzer N, Eklund AC, Han J, Nemunaitis J. Tong AW, et al. Among authors: nemunaitis j. Cancer Gene Ther. 2009 Mar;16(3):206-16. doi: 10.1038/cgt.2008.77. Epub 2008 Oct 24. Cancer Gene Ther. 2009. PMID: 18949015

7

siRNA vs. shRNA: similarities and differences.

Rao DD, Vorhies JS, Senzer N, Nemunaitis J. Rao DD, et al. Among authors: nemunaitis j. Adv Drug Deliv Rev. 2009 Jul 25;61(9):746-59. doi: 10.1016/j.addr.2009.04.004. Epub 2009 Apr 20. Adv Drug Deliv Rev. 2009. PMID: 19389436 Review.

8

Comparative assessment of siRNA and shRNA off target effects: what is slowing clinical development.

Rao DD, Senzer N, Cleary MA, Nemunaitis J. Rao DD, et al. Among authors: nemunaitis j. Cancer Gene Ther. 2009 Nov;16(11):807-9. doi: 10.1038/cgt.2009.53. Epub 2009 Aug 28. Cancer Gene Ther. 2009. PMID: 19713999 Review.

9

Letter to the editor: Does dicer expression affect shRNA processing?

Senzer N, Rao D, Nemunaitis J. Senzer N, et al. Among authors: nemunaitis j. Gene Regul Syst Bio. 2009 Jun 19;3:103-4. doi: 10.4137/grsb.s2551. Gene Regul Syst Bio. 2009. PMID: 19838337 Free PMC article.

10

Enhanced target gene knockdown by a bifunctional shRNA: a novel approach of RNA interference.

Rao DD, Maples PB, Senzer N, Kumar P, Wang Z, Pappen BO, Yu Y, Haddock C, Jay C, Phadke AP, Chen S, Kuhn J, Dylewski D, Scott S, Monsma D, Webb C, Tong A, Shanahan D, Nemunaitis J. Rao DD, et al. Among authors: nemunaitis j. Cancer Gene Ther. 2010 Nov;17(11):780-91. doi: 10.1038/cgt.2010.35. Epub 2010 Jul 2. Cancer Gene Ther. 2010. PMID: 20596090

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

396 results

Search Page

Filters